1.Tellez-Zenteno, JF, Patten, SB, Jetté, N, Williams, J, Wiebe, S. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia. 2007;48:2336–2344.
2.Forsgren, L, Nystrom, L. An incident case-referent study of epileptic seizures in adults. Epilepsy Res. 1990;6:66–81.
3.Hesdorffer, DC, Hauser, WA, Annegers, JF, Cascino, G. Major depression is a risk factor for seizures in older adults. Ann Neurol. 2000;47:246–249.
4.Hesdorffer, DC, Hauser, WA, Olafsson, E, Ludvigsson, P, Kjartansson, O. Depression and suicidal attempt as risk factor for incidental unprovoked seizures. Ann Neurol. 2006;59:35–41.
5.Christensen, J, Vestergaard, M, Mortensen, P, Sidenius, P, Agerbo, E. Epilepsy and risk of suicide: a population-based case—control study. Lancet Neurol. 2007;6:693–698.
6.Lehrner, J, Kalchmayr, R, Serles, W et al. , Health-related quality of life (HRQOL), activity of daily living (ADL) and depressive mood disorder in temporal lobe epilepsy patients. Seizure. 1999;8:88–92.
7.Perrine, K, Hermann, BP, Meador, KJ et al. , The relationship of neuropsychological functioning to quality of life in epilepsy. Arch Neurol. 1995;52:997–1003.
8.Gilliam, F, Kuzniecky, R, Faught, E et al. , Patient-validated content of epilepsy-specific quality-of-life measurement. Epilepsia. 1997;38:233–236.
9.Boylan, LS, Flint, LA, Labovitz, DL, Jackson, SC, Starner, K, Devinsky, O. Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy. Neurology. 2004;62:258–261.
10.Cramer, JA, Blum, M, Reed, M, Fanning, K, Epilepsy Impact Project. The influence of comorbid depression on quality of life for people with epilepsy. Epilepsy Behav. 2003;4:515–521.
11.Cramer, JA, Blum, D, Fanning, K, Reed, M, Epilepsy Impact Project Group. The impact of comorbid depression on health resource utilization in a community sample of people with epilepsy. Epilepsy Behav. 2004;5:337–342.
12.Hitiris, N, Mohanraj, R, Norrie, J, Sills, GJ, Brodie, MJ. Predictors of pharmacoresistant epilepsy. Epilepsy Res. 2007;75:192–196.
13.Kanner, AM, Byrne, R, Chicharro, A, Wuu, J, Frey, M. A lifetime psychiatric history predicts a worse seizure outcome following temporal lobectomy. Neurology. 2009;72:793–799.
14.Kanner, AM, Balabanov, A. Depression in epilepsy: how closely related are these two disorders? Neurology. 2002;58(suppl 5):27–39.
15.Kanner, AM. Depression and epilepsy: why is their relation is so close? Neurol Clin N Am. 2009;27:865–880.
16.Kanner, AM. Depression and epilepsy: do glucocorticoids and glutamate explain their relationship? Curr Neurol Neurosci Rep. 2009;9:307–312.
17.Kanner, AM. Mood disorder and epilepsy: a neurobiologic perspective of their relationship. Dialogues Clin Neurosci. 2008;10:39–45.
18.Kanner, AM. Current review in clinical science: depression in epilepsy: a neurobiologic perspective. Epilepsy Curr. 2005;5:21–27.
19.Diagnostic and Statistical Manuel of Mental Disorders. 4th ed, text rev. Washington, DC: American Psychiatric Association; 2000.
20.Kraepelin, E. Psychiatrie, vol 3. Leipzig: Johann Ambrosius Barth, 1923.
21.Bleuler, E. Lehrbuch der Psychiatrie. 8th ed.Berlin: Springer, 1949.
22.Blumer, D, Altshuler, LL. Affective disorders. In: Engel, J, Pedley, TA, eds. Epilepsy: A Comprehensive Textbook, vol 2. Philadelphia, PA: Lippincott-Raven; 1998:2083–2099.
23.Blanchet, P, Frommer, GP. Mood change preceding epileptic seizures. J Nerv Ment Dis. 1986;174:471–476.
24.Kanner, AM, Soto, A, Gross-Kanner, H. Prevalence and clinical characteristics of postictal psychiatric symptoms in partial epilepsy. Neurology. 2004;62:708–713.
25.Jones, JE, Herman, BP, Berry, JJ, Gilliam, F, Kanner, AM, Meador, KJ. Clinical assessment of Axis I psychiatric morbidity in chronic epilepsy: a multicenter investigation. J Neuropsychiatry Clin Neurosci. 2005;17:172–179.
26.Jones, JE, Hermann, BP, Barry, JJ, Gilliam, FG, Kanner, AM, Meador, KJ. Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy. Epilepsy Behav. 2003;4(suppl 3):31–38.
27.Labiner, DM, Ettinger, AB, Fakhoury, TA et al. , Effects of lamotrigine compared with levetiracetam on anger, hostility, and total mood in patients with partial epilepsy. Epilepsia. 2009;50:434–442.
28.Fakhoury, TA, Miller, JM, Hammer, AE, Vuong, A. Effects of lamotrigine on mood in older adults with epilepsy and co-morbid depressive symptoms: an open-label, multicentre, prospective study. Drugs Aging. 2008;25:955–962.
29.Fakhoury, TA, Barry, JJ, Mitchell Miller, J, Hammer, AE, Vuong, A. Lamotrigine in patients with epilepsy and comorbid depressive symptoms. Epilepsy Behav. 2007;10:155–162.
30.Charney, DS, Berman, RM, Miller, HL. Treatment of depression. In: Schatzberg, AF, Nemeroff, CB, eds. Textbook of Psychopharmacology. 2nd ed.Washington, DC: American Psychiatric Association Press; 1998: 705–732.
31.U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Office of Translational Sciences, Office of Biostatistics (2008). Statistical review and evaluation: Antiepileptic drugs and suicidality. May 21, 2008.
32.Hesdorffer, DC, Kanner, AM. The FDA alert on suicidality and antiepileptic drugs: fire or false alarm? Epilepsia. 2009;50:978–986.
33.Gilliam, FG, Barry, JJ, Hermann, BP, Meador, KJ, Vahle, V, Kanner, AM. Rapid detection of major depression in epilepsy: a multicentre study. Lancet Neurol. 2006;5:399–405.
34.Kroenke, K, Spitzer, RL, Williams, JB, Monahan, PO, Löwe, B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007;146:317–325.